February 2022: Atlanta-based Axion Biosystems Inc has acquired Oxford-based M-Solv Manufacturing Ltd – which provides pharmaceutical companies, biotechnology firms, and research scientists with a state-of-the-art cell analysis platform for disease modelling and drug discovery. Axion BioSystems was advised by Kinetix Critchleys Corporate Finance (KCCF).
About Axion Biosystems
Since 2017, M-Solv has supplied Atlanta-based Axion BioSystems with high-resolution proprietary printed electronics circuits, a critical consumable used in Axion’s flagship Maestro Pro multielectrode array benchtop instrument. The system provides pharmaceutical companies, biotechnology firms, and research scientists with a state-of-the-art cell analysis platform for disease modelling and drug discovery.
Tom O’Brien, CEO of Axion Biosystems stated: “This vertical integration not only ensures that our customers have the products they need to conduct critical biomedical research; it also allows us to advance assay plate technologies more rapidly to meet the increasingly complex scientific demands of our users.”
Phil Rumsby, CEO of M-Solv Manufacturing Limited: “As part of the Axion Group, we are looking forward to working together even more closely to grow this part of our business as we develop the next generation of bioelectronic assay consumables. Alongside our biosensor business, we will continue to maintain and grow our strong position in touch-panel devices.”
Axion’s announcement can be found here.
About us: Kinetix Critchleys Corporate Finance is an independent corporate advisory boutique, with sector specialisms in Sustainability & Cleantech, Hard & Soft tech, Financial Services including Fintech, and Healthcare. We provide strategic and M&A advice, business planning, valuations and fund raising services.